Preemptive pharmacologic intervention in radiation-induced salivary dysfunction

Area of Science:

• Oncology
• Radiology
• Dentistry
• Pathophysiology

Background:

• Xerostomia (dry mouth) is a common side effect of pharmacotherapy and cancer treatments.
• Severe salivary dysfunction, including xerostomia, often results from damage or loss of salivary acinar cells.
• Therapeutic irradiation for head and neck cancer or bone marrow transplantation can cause significant iatrogenic salivary gland destruction.

Purpose of the Study:

• To review the pathophysiology of radiation-induced salivary damage in humans and animals.
• To discuss animal studies investigating strategies to modify and clarify this process.
• To present early clinical trial results on protecting salivary glands during therapeutic irradiation.

Main Methods:

• Review of human and animal pathophysiology of radiation-induced salivary damage.
• Discussion of animal studies using various strategies to modify radiation-induced salivary damage.
• Analysis of early clinical trial data on salivary gland protection during irradiation.

Main Results:

• Salivary glands are highly radiosensitive, though the mechanism is not fully understood.
• Radiation-induced salivary damage can lead to debilitating xerostomia, affecting nutrition and speech.
• Early clinical trials suggest potential for protecting salivary glands during therapeutic irradiation.

Conclusions:

• Radiation-induced salivary gland damage is a significant clinical problem, leading to xerostomia.
• Animal studies provide insights into the mechanisms and potential protective strategies.
• Emerging clinical evidence suggests that salivary gland protection during irradiation may be achievable.